B. Waeber

1.5k total citations
67 papers, 1.3k citations indexed

About

B. Waeber is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, B. Waeber has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 15 papers in Molecular Biology and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in B. Waeber's work include Hormonal Regulation and Hypertension (14 papers), Blood Pressure and Hypertension Studies (11 papers) and Pharmacogenetics and Drug Metabolism (10 papers). B. Waeber is often cited by papers focused on Hormonal Regulation and Hypertension (14 papers), Blood Pressure and Hypertension Studies (11 papers) and Pharmacogenetics and Drug Metabolism (10 papers). B. Waeber collaborates with scholars based in Switzerland, China and United Kingdom. B. Waeber's co-authors include J. Nussberger, Hans R. Brunner, Heinrich Brunner, J Nussberger, H R Brunner, Brunner Hr, Juerg Nussberger, T. Fasanella D'amore, Robert J. Francis and AN Brown and has published in prestigious journals such as Hypertension, Journal of Pharmacology and Experimental Therapeutics and Cardiovascular Research.

In The Last Decade

B. Waeber

66 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Waeber Switzerland 21 665 327 272 140 135 67 1.3k
H R Brunner Switzerland 22 991 1.5× 426 1.3× 384 1.4× 125 0.9× 193 1.4× 48 1.5k
G. J. Wenting Netherlands 20 634 1.0× 275 0.8× 267 1.0× 78 0.6× 121 0.9× 36 1.1k
Heinrich Brunner Switzerland 20 1.0k 1.5× 385 1.2× 389 1.4× 140 1.0× 109 0.8× 51 1.6k
Roger K. Ferguson United States 22 461 0.7× 282 0.9× 148 0.5× 83 0.6× 121 0.9× 71 1.2k
J. A. Millar United Kingdom 17 665 1.0× 403 1.2× 260 1.0× 66 0.5× 245 1.8× 66 1.4k
Thomas Thulin Sweden 21 466 0.7× 451 1.4× 163 0.6× 119 0.8× 103 0.8× 64 1.5k
D. B. Brunner Switzerland 15 777 1.2× 494 1.5× 346 1.3× 131 0.9× 193 1.4× 21 1.2k
Nathaniel Winer United States 19 600 0.9× 302 0.9× 434 1.6× 98 0.7× 64 0.5× 52 1.6k
Ole Lederballe Pedersen Denmark 27 1.2k 1.9× 274 0.8× 270 1.0× 88 0.6× 101 0.7× 64 2.2k
M Porchet Switzerland 16 797 1.2× 310 0.9× 317 1.2× 78 0.6× 100 0.7× 30 1.1k

Countries citing papers authored by B. Waeber

Since Specialization
Citations

This map shows the geographic impact of B. Waeber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Waeber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Waeber more than expected).

Fields of papers citing papers by B. Waeber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Waeber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Waeber. The network helps show where B. Waeber may publish in the future.

Co-authorship network of co-authors of B. Waeber

This figure shows the co-authorship network connecting the top 25 collaborators of B. Waeber. A scholar is included among the top collaborators of B. Waeber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Waeber. B. Waeber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bardy, Daniel, et al.. (2014). High mobility group box 1 protein (HMGB-1): A pathogenic role in preeclampsia?. Placenta. 35(9). 784–786. 33 indexed citations
2.
Waeber, B., et al.. (2012). PP125. High mobility group box 1 protein (HMGB1): A pathogenic role in preeclampsia?. Pregnancy Hypertension. 2(3). 306–307.
3.
Loukili, Noureddine, Nathalie Rosenblatt‐Velin, Li Ju, et al.. (2010). Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo. Cardiovascular Research. 89(3). 586–594. 69 indexed citations
4.
Szucs, Thomas D., B. Waeber, & Yuki Tomonaga. (2009). Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective. Journal of Human Hypertension. 24(2). 117–123. 10 indexed citations
5.
Epstein, Murray & B. Waeber. (2002). Fixed-dose combination therapy with calcium antagonists.. IRIS. 2 indexed citations
6.
Waeber, B., et al.. (1999). IMPROVED BLOOD PRESSURE CONTROL BY MONITORING COMPLIANCE WITH ANTIHYPERTENSIVE THERAPY. International Journal of Clinical Practice. 53(1). 37–38. 41 indexed citations
7.
Waeber, B.. (1998). Potential Cardioprotective Effect of Mibefradil in the Long-Term Treatment of Hypertension. Cardiology. 89(Suppl. 1). 16–22. 3 indexed citations
8.
Evéquoz, D, Eric Grouzmann, Jürg Nussberger, et al.. (1995). Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats. Regulatory Peptides. 58(3). 163–166. 5 indexed citations
9.
Waeber, B., Michel Burnier, G Heynen, & H R Brunner. (1994). Clinical Utility of Ambulatory Blood Pressure Monitoring in the Evaluation of Patients with Borderline Hypertension. European Journal of Cardiovascular Prevention & Rehabilitation. 1(2). 120–126. 3 indexed citations
10.
Brunner, Hans R., J. Nussberger, & B. Waeber. (1993). Inhibitors of the renin-angiotensin system.. PubMed. 43(2A). 274–8. 6 indexed citations
11.
Brunner, Hans R., J. Nussberger, & B. Waeber. (1993). Control of vascular tone by renin and angiotensin in cardiovascular disease.. PubMed. 14 Suppl I. 149–53. 8 indexed citations
12.
Brunner, Hans R., J. Nussberger, & B. Waeber. (1993). Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.. PubMed. 11(3). S53–8. 26 indexed citations
13.
Pedrazzini, Thierry, et al.. (1993). Neuropeptide Y and cardiovascular regulation. Current Opinion in Nephrology & Hypertension. 2(1). 106–113. 17 indexed citations
14.
Brunner, Hans R., J. Nussberger, & B. Waeber. (1990). Various approaches to blockade of the renin-angiotensin system: persistent renin response.. PubMed. 8(7). S149–53. 4 indexed citations
15.
Waeber, B., et al.. (1990). Prevention of renal hypertension in the rat by neuropeptide Y. Journal of Hypertension. 8(1). 21–25. 30 indexed citations
16.
Nussberger, Juerg, et al.. (1990). Caffeine-Induced Diuresis and Atrial Natriuretic Peptides. Journal of Cardiovascular Pharmacology. 15(5). 685–691. 68 indexed citations
17.
Hr, Brunner, B. Waeber, & J. Nussberger. (1988). Renin secretion responsiveness: understanding the efficacy of renin-angiotensin inhibition.. PubMed. 26. S80–5. 4 indexed citations
18.
Aubert, Jean-François, B. Waeber, J. Nussberger, et al.. (1988). Influence of Endogenous Bradykinin on Acute Blood Pressure Response to Vasopressors in Normotensive Rats Assessed with a Bradykinin Antagonist. Journal of Cardiovascular Pharmacology. 11(1). 51–55. 14 indexed citations
19.
Brunner, Hans R., J. Bidiville, Gérard Waeber, et al.. (1987). Angiotensin-Converting Enzyme Inhibitor versus Calcium Antagonist in the Treatment of Hypertension. ˜The œNephron journals/Nephron journals. 47(1). 87–89. 7 indexed citations
20.
Francis, Robert J., AN Brown, Lata Kler, et al.. (1987). Pharmacokinetics of the Converting Enzyme Inhibitor Cilazapril in Normal Volunteers and the Relationship to Enzyme Inhibition: Development of a Mathematical Model. Journal of Cardiovascular Pharmacology. 9(1). 32–38. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H R Brunner Breakdown of academic impact, for papers by G. J. Wenting Breakdown of academic impact, for papers by Heinrich Brunner Breakdown of academic impact, for papers by Roger K. Ferguson Breakdown of academic impact, for papers by J. A. Millar Breakdown of academic impact, for papers by Thomas Thulin Breakdown of academic impact, for papers by D. B. Brunner Breakdown of academic impact, for papers by Nathaniel Winer Breakdown of academic impact, for papers by Ole Lederballe Pedersen Breakdown of academic impact, for papers by M Porchet
Rankless by CCL
2026